Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Various Gvhd Prophylaxis Regimens Influence Differently T-Memory Cell Subsets Recovery after Allogeneic Stem Cell Transplantation in Leukemia Patients

Mikhail Drokov, Natalia Popova, MD, Elena Parovichnikova, MD PhD, Larisa Kuzmina, PhD, Julia Davydova, Nikolay Kapranov, Ekaterina Mikhaltsova, PhD, Olga Koroleva, Vera Vasilyeva, Daria Dubnyak, Zoya Konova, Anna Sidorova, Ekterina Usikova, Anna Dmitrova, Irina V. Galtseva, PhD, Mikhail Maschan, PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 5717.

https://doi.org/10.1182/blood-2018-99-114688

Published: 2018

Journal Articles

Post-Transplant Cyclophosphomide Spares Granzyme B Expression in T Regulatory Cells (Treg), but Not in CD8+ T and NK Cells after Allogeneic HSCT

Mikhail Drokov, MDPhD, Elena N. Parovichnikova, MD PhD, Larisa A. Kuzmina, MD PhD, Vera Vasilieva, Ekaterina Mikhaltsova, Olga Koroleva, Daria Dubnyak, Irina Galtseva, Valeri Savchenko, MD PhD Prof.

Blood (2015) 126 (23): 5422.

https://doi.org/10.1182/blood.V126.23.5422.5422

Published: 2015

Journal Articles

Reconstitution of Memory T -Cells after Allogeneic Stem Cell Transplantation in Patients with Post-Transplantation Cyclophosphamide As Tolerance Induction

Vera Vasilyeva, Elena N. Parovichnikova, MD PhD, Larisa A. Kuzmina, MD PhD, Mikhail Drokov, MD PhD, Ekaterina Mikhaltsova, Olga Koroleva, Daria Dubnyak, Irina Galtseva, Valeri G. Savchenko

Blood (2015) 126 (23): 5475.

https://doi.org/10.1182/blood.V126.23.5475.5475

Published: 2015

Journal Articles

Long-Term Efficacy of the Combined Immunosuppressive Therapy (IST): Cyclosporine with/without Splenectomy - in Patients with Different Forms of Myelodysplastic Syndromes

Valeri G Savchenko, MD, PhD, Alina Kokhno, MD, PhD, Elena N. Parovichnikova, MD PhD, Elena Mikhailova, MD, PhD, Vera V. Troitskaya, MD PhD, Larisa A. Kuzmina, MD PhD, Mikhail Drokov, MDPhD, Valentina N. Dvirnyk, MD, PhD, Alla M. Kovrigina, MD PhD Prof., Tatiana N. Obukhova, PhD

Blood (2015) 126 (23): 5238.

https://doi.org/10.1182/blood.V126.23.5238.5238

Published: 2015

Journal Articles

Low Density Granulocytes in Patients after Allogeneic Hematopoietic Stem Cells Transplantation (allo-HSCT): A Distinct Class of Neutrophils in Systemic Alloimmunity

Ekaterina Mikhaltsova, Valeri G. Savchenko, Larisa A. Kuzmina, MD PhD, Mikhail Drokov, MDPhD, Vera Vasilyeva, Olga Koroleva, Daria Dubnyak, Elena N. Parovichnikova, MD PhD

Blood (2015) 126 (23): 4614.

https://doi.org/10.1182/blood.V126.23.4614.4614

Published: 2015

Journal Articles

Low Percent of Granzyme B Positive T-Regulatory Cells (CD4 + CD25 high ) As a Predictor of Acute Graft-Versus-Host Disease (GVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)

Mikhail Drokov, MD, Elena N. Parovichnikova, MD PhD, Larisa A Kuzmina, MD, Irina Galtseva, PhD, Vera Vasilieva, MD, Valeri G. Savchenko, MD PhD Prof.

Blood (2014) 124 (21): 5871.

https://doi.org/10.1182/blood.V124.21.5871.5871

Published: 2014

Journal Articles

Post-Transplantation Cyclophosphamide and Mesenchymal Stem Cells Infusion For Graft-Versus-Host Prophylaxis For Patients With Advanced Disease After Allogenic Bone Marrow Transplantation

Mikhail Drokov, M.D., Elena Parovichnikova, Larisa Kuzmina, Vera Vasilyeva, M.D., Alexandra Karyakina, M.D, Gennadyi Galstian, M.D, PhD, Valeri G. Savchenko, MD, PhD

Blood (2013) 122 (21): 5476.

https://doi.org/10.1182/blood.V122.21.5476.5476

Published: 2013

NARROW

Various Gvhd Prophylaxis Regimens Influence Differently T-Memory Cell Subsets Recovery after Allogeneic Stem Cell Transplantation in Leukemia Patients

Post-Transplant Cyclophosphomide Spares Granzyme B Expression in T Regulatory Cells (Treg), but Not in CD8+ T and NK Cells after Allogeneic HSCT

Reconstitution of Memory T -Cells after Allogeneic Stem Cell Transplantation in Patients with Post-Transplantation Cyclophosphamide As Tolerance Induction

Long-Term Efficacy of the Combined Immunosuppressive Therapy (IST): Cyclosporine with/without Splenectomy - in Patients with Different Forms of Myelodysplastic Syndromes

Low Density Granulocytes in Patients after Allogeneic Hematopoietic Stem Cells Transplantation (allo-HSCT): A Distinct Class of Neutrophils in Systemic Alloimmunity

Low Percent of Granzyme B Positive T-Regulatory Cells (CD4 + CD25 high ) As a Predictor of Acute Graft-Versus-Host Disease (GVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)

Post-Transplantation Cyclophosphamide and Mesenchymal Stem Cells Infusion For Graft-Versus-Host Prophylaxis For Patients With Advanced Disease After Allogenic Bone Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

Various Gvhd Prophylaxis Regimens Influence Differently T-Memory Cell Subsets Recovery after Allogeneic Stem Cell Transplantation in Leukemia Patients

Post-Transplant Cyclophosphomide Spares Granzyme B Expression in T Regulatory Cells (Treg), but Not in CD8+ T and NK Cells after Allogeneic HSCT

Reconstitution of Memory T -Cells after Allogeneic Stem Cell Transplantation in Patients with Post-Transplantation Cyclophosphamide As Tolerance Induction

Long-Term Efficacy of the Combined Immunosuppressive Therapy (IST): Cyclosporine with/without Splenectomy - in Patients with Different Forms of Myelodysplastic Syndromes

Low Density Granulocytes in Patients after Allogeneic Hematopoietic Stem Cells Transplantation (allo-HSCT): A Distinct Class of Neutrophils in Systemic Alloimmunity

Low Percent of Granzyme B Positive T-Regulatory Cells (CD4 + CD25 high ) As a Predictor of Acute Graft-Versus-Host Disease (GVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)

Post-Transplantation Cyclophosphamide and Mesenchymal Stem Cells Infusion For Graft-Versus-Host Prophylaxis For Patients With Advanced Disease After Allogenic Bone Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only